tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal has been researched along with beta-endorphin in 1 studies
| Studies (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal) | Trials (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal) | Recent Studies (post-2010) (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal) | Studies (beta-endorphin) | Trials (beta-endorphin) | Recent Studies (post-2010) (beta-endorphin) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 6,480 | 409 | 444 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barna, I; Gráf, L; Makara, GB; Rappay, G | 1 |
1 other study(ies) available for tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal and beta-endorphin
| Article | Year |
|---|---|
A serine-proteinase inhibitor (Boc-D-Phe-Pro-Arg-H) inhibits the secretion of adrenocorticotropin- and beta-endorphin-immunoreactive peptides in vitro.
Topics: Adrenocorticotropic Hormone; Animals; beta-Endorphin; beta-Lipotropin; Cells, Cultured; Dose-Response Relationship, Drug; Endorphins; Female; Median Eminence; Oligopeptides; Pituitary Gland, Anterior; Protease Inhibitors; Rats | 1982 |